adenosine amine congener has been researched along with adenosine in 18 studies
| Studies (adenosine amine congener) | Trials (adenosine amine congener) | Recent Studies (post-2010) (adenosine amine congener) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
|---|---|---|---|---|---|
| 29 | 0 | 5 | 32,536 | 1,075 | 8,930 |
| Protein | Taxonomy | adenosine amine congener (IC50) | adenosine (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
| Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
| Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
| Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
| Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berkich, DA; Dean, RL; Eveleth, D; Hiramatsu, K; Jacobson, KA; Ji, XD; Kassell, NF; Lee, KS; Nikodijevic, O; van Galen, PJ | 1 |
| Balcells, E; Rubio, R; Suarez, J | 1 |
| Beenhakker, M; Bischofberger, N; Carter, MF; Jacobson, KA; Lin, RC; Paul, IA; Von Lubitz, DK | 1 |
| Beenhakker, M; Bischofberger, N; Boyd, M; Jacobson, KA; Lin, RC; Paul, IA; Von Lubitz, DK | 1 |
| Kim, YH; Song, DK; Suh, HW | 1 |
| Bischofberger, N; Jacobson, KA; von Lubitz, DK | 1 |
| Beenhakker, M; Bischofberger, N; Boyd, M; Jacobson, KA; Lin, RC; Lipartowska, R; Von Lubitz, DK | 1 |
| Adén, U; Fredholm, BB; Hagberg, H; Leverin, AL | 1 |
| Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Lambert, DG | 1 |
| Fowler, JC; Gervitz, LM; Hamilton, ME; Lutherer, LO | 1 |
| Ceballos, G; Rubio, R | 1 |
| Bantubungi, K; Blum, D; d'Alcantara, P; Galas, MC; Gall, D; Schiffmann, SN | 1 |
| Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW | 1 |
| Karlik, SJ; Messersmith, E; Meyer-Franke, A; Roscoe, WA; Wipke, B | 1 |
| Barrett, CJ; Bennet, L; Booth, LC; Gunn, AJ; Jensen, EC; Malpas, SC; Tummers, L | 1 |
| Civan, MM; Do, CW; Karl, MO; Leung, CT; Li, A; Macknight, AD; McLaughlin, CW; Stone, RA; Wang, Z; Zellhuber-McMillan, S | 1 |
| Chang, H; Chi, HH; Housley, GD; Paek, SY; Sreebhavan, S; Telang, RS; Thorne, PR; Tingle, M; Vlajkovic, SM | 1 |
| Chang, H; Sreebhavan, S; Telang, RS; Thorne, PR; Tingle, M; Vlajkovic, SM | 1 |
1 review(s) available for adenosine amine congener and adenosine
| Article | Year |
|---|---|
Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Cell Survival; Humans; Ischemic Attack, Transient; Neurons; Neuroprotective Agents; Purinergic P1 Receptor Agonists | 1997 |
17 other study(ies) available for adenosine amine congener and adenosine
| Article | Year |
|---|---|
Synthesis and biological activity of N6-(p-sulfophenyl)alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonists.
Topics: Adenosine; Animals; Body Temperature; Brain; Evoked Potentials; Gerbillinae; In Vitro Techniques; Lipolysis; Male; Mice; Motor Activity; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Solubility; Structure-Activity Relationship; Sulfonic Acids | 1992 |
Functional role of intravascular coronary endothelial adenosine receptors.
Topics: Adenosine; Animals; Atrioventricular Node; Coronary Circulation; Coronary Vessels; Endothelium, Vascular; Glycogen; Guinea Pigs; Heart Rate; Latex; Male; Microspheres; Myocardial Contraction; Receptors, Purinergic; Vascular Resistance; Ventricular Function | 1992 |
Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist.
Topics: Adenosine; Analysis of Variance; Animals; Behavior, Animal; Brain Ischemia; Female; Gerbillinae; Maze Learning; Memory; Motor Activity; Purinergic P1 Receptor Agonists | 1996 |
Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils.
Topics: Adenosine; Animals; Brain Ischemia; Cell Survival; Female; Gerbillinae; Hippocampus; Immunohistochemistry; Prognosis | 1996 |
Differential effects of adenosine receptor antagonists injected intrathecally on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the mouse.
Topics: Adenosine; Analgesics; Animals; beta-Endorphin; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morphine; Phenethylamines; Purinergic P1 Receptor Antagonists; Reaction Time; Theobromine; Xanthines | 1997 |
Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.
Topics: Adenosine; Analysis of Variance; Animals; Brain Ischemia; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gerbillinae; Hippocampus; Injections, Intraperitoneal; Purinergic P1 Receptor Agonists | 1999 |
Adenosine A(1) receptor agonism in the immature rat brain and heart.
Topics: Adenosine; Animals; Animals, Newborn; Binding, Competitive; Body Temperature; Brain; Brain Ischemia; Dose-Response Relationship, Drug; Female; Guanosine 5'-O-(3-Thiotriphosphate); Heart; Heart Rate; Hypoxia; Iodine Radioisotopes; Male; Myocardium; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Rectum; Sulfur Radioisotopes; Time Factors; Xanthines | 2001 |
Vasodilator responses to adenosine and hyperemia are mediated by A(1) and A(2) receptors in the cat vascular bed.
Topics: Adenosine; Adenosine Triphosphate; Animals; Cats; Dose-Response Relationship, Drug; Female; Hemodynamics; Hindlimb; Hyperemia; Male; Perfusion; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Triazoles; Vascular Resistance; Vasodilation; Xanthines | 2002 |
Lack of central effects of peripherally administered adenosine A(1) agonists on synaptic transmission in the rat hippocampus.
Topics: Adenosine; Animals; Cardiovascular Physiological Phenomena; Excitatory Postsynaptic Potentials; Hippocampus; Hypoxia-Ischemia, Brain; Male; Neurons; Neuroprotective Agents; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Synapses; Synaptic Transmission; Theophylline | 2002 |
Sole activation of three luminal adenosine receptor subtypes in different parts of coronary vasculature.
Topics: Adenosine; Animals; Aorta; Coronary Vessels; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guinea Pigs; Heart; In Vitro Techniques; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Perfusion; Phenethylamines; Polymers; Protein Isoforms; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Vasoconstriction; Vasodilation | 2003 |
The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.
Topics: Adenosine; Animals; Behavior, Animal; Binding, Competitive; Body Weight; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dystonia; Enkephalins; Hindlimb; Huntington Disease; In Vitro Techniques; Male; Mitochondria; Motor Activity; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Propionates; Purinergic P1 Receptor Agonists; Rats; Rats, Inbred Lew; Reproducibility of Results; RNA, Messenger; Succinate Dehydrogenase; Synaptic Transmission; Treatment Outcome | 2002 |
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Caffeine; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1; Macrophages; Matrix Metalloproteinase 12; Metalloendopeptidases; Mice; Mice, Knockout; Microglia; Multiple Sclerosis; Myelin Sheath; Phenotype; Receptor, Adenosine A1; Recurrence; RNA, Messenger; Severity of Illness Index; Spinal Cord; Up-Regulation | 2004 |
Connexin 43 gap junction proteins are up-regulated in remyelinating spinal cord.
Topics: Adenosine; Animals; Antibodies; Connexin 43; Connexins; Encephalomyelitis, Autoimmune, Experimental; Female; Guinea Pigs; Integrin alpha4; Myelin Sheath; Nerve Regeneration; Recovery of Function; Spinal Cord; Up-Regulation | 2007 |
Differential effects of the adenosine A1 receptor agonist adenosine amine congener on renal, femoral and carotid vascular conductance in preterm fetal sheep.
Topics: Adenosine; Animals; Carotid Arteries; Female; Femoral Artery; Fetus; Pregnancy; Premature Birth; Regional Blood Flow; Renal Circulation; Sheep, Domestic | 2008 |
Electron probe X-ray microanalysis of intact pathway for human aqueous humor outflow.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Aqueous Humor; Cell Size; Chlorides; Electron Probe Microanalysis; Enzyme Inhibitors; Feasibility Studies; Humans; Hypotonic Solutions; Intraocular Pressure; Norbornanes; Osmotic Pressure; Ouabain; Phenethylamines; Phosphorus; Potassium; Receptor, Adenosine A1; Receptors, Adenosine A2; Sodium; Sodium-Potassium-Exchanging ATPase; Trabecular Meshwork | 2008 |
Adenosine amine congener as a cochlear rescue agent.
Topics: Adenosine; Animals; Cochlea; Dose-Response Relationship, Drug; Evoked Potentials, Auditory, Brain Stem; Hearing Loss, Noise-Induced; Injections, Intraperitoneal; Injections, Intravenous; Male; Protective Agents; Rats; Rats, Wistar | 2014 |
Pharmacokinetic Properties of Adenosine Amine Congener in Cochlear Perilymph after Systemic Administration.
Topics: Adenosine; Animals; Cochlea; Hearing Loss, Noise-Induced; Male; Perilymph; Rats; Rats, Wistar | 2017 |